Ocugen (OCGN) CFO discloses options and share holdings in Form 3

Rhea-AI Filing Summary

Ocugen, Inc. Chief Financial Officer Treerita Essalima Johnson-Greene filed an initial statement of beneficial ownership. The filing reports 750,000 options to buy Ocugen stock and 500,000 common shares held directly, plus 350 common shares held indirectly by a spouse.

The reported option vests in equal annual installments over three years beginning on February 17, 2027, subject to continued service with the company on each vesting date. This filing establishes the CFO’s starting equity position as a reporting insider.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Johnson-Greene Treerita Essalima

(Last) (First) (Middle)

C/O OCUGEN, INC.

11 GREAT VALLEY PARKWAY

(Street)

MALVERN PA 19355

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/04/2026

3. Issuer Name and Ticker or Trading Symbol
Ocugen, Inc. [ OCGN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	500,000	D
Common Stock	350	I	By Spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	(1)	02/17/2036	Common Stock	750,000	$1.44	D

Explanation of Responses:

1. The option vests annually in equal installments over three years commencing on February 17, 2027, subject to continued service with the Issuer on the applicable vesting dates.

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Treerita E. Johnson-Greene by Shankar Musunuri, her attorney-in-fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Ocugen (OCGN) CFO Treerita Johnson-Greene report on this Form 3?

The Ocugen CFO reports her initial beneficial ownership, including options on 750,000 shares and 500,000 common shares held directly, plus 350 shares held indirectly through her spouse, establishing her baseline equity stake as a newly reporting insider.

How many Ocugen (OCGN) stock options does the CFO report owning?

She reports owning options on 750,000 Ocugen shares. According to the disclosure, these options are scheduled to vest in equal annual installments over three years, starting on February 17, 2027, contingent on her continued service with the company.

When do the Ocugen (OCGN) CFO’s stock options begin vesting?

The options begin vesting on February 17, 2027. They vest annually in equal installments over three years, and each vesting date requires that she continue serving with Ocugen, aligning long-term compensation with ongoing employment at the company.

How many Ocugen (OCGN) common shares does the CFO hold directly and indirectly?

She holds 500,000 Ocugen common shares directly and 350 common shares indirectly through her spouse. This split shows both personal and family-related holdings, all reported together as part of her overall beneficial ownership position.

What is the purpose of this Ocugen (OCGN) Form 3 filing by the CFO?

This Form 3 serves as the CFO’s initial statement of beneficial ownership in Ocugen. It discloses her existing equity interests, including options and common shares, when she becomes a reporting insider under SEC rules, providing transparency to investors.